Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Lumena Fails To Clear Accusations

by Jean-François Tremblay
December 8, 2014 | A version of this story appeared in Volume 92, Issue 49

Lumena, a Chinese producer of laxatives and engineering plastics, has announced it is unable to resume trading on the Hong Kong Stock Exchange. This spring, the short-selling firms Glaucus Research and Emerson Analytics accused Lumena of lying to investors (C&EN, Oct. 13, page 17). Their reports led to suspension of the Chinese firm’s trading in Hong Kong. Lumena now says it can’t meet conditions imposed by the Hong Kong Stock Exchange. It wants Lumena to release its audited financial results for 2013, issue a convincing rebuttal of the allegations made by Emerson and Glaucus, and prove that it’s a large enough concern to be listed in Hong Kong.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.